The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-center experience with advanced liposarcoma (LPS): Overall survival (OS), prognostic factors and chemotherapy outcome.
 
Jasmien Cornillie
No Relationships to Disclose
 
Thomas Van Cann
Travel, Accommodations, Expenses - PharmaMar
 
Raf Vandeweyer
No Relationships to Disclose
 
Agnieszka Wozniak
No Relationships to Disclose
 
Maria Debiec-Rychter
No Relationships to Disclose
 
Raf Sciot
No Relationships to Disclose
 
Daphne Hompes
No Relationships to Disclose
 
Patrick Schöffski
Honoraria - Daiichi Sankyo; Medpace
Consulting or Advisory Role - Adaptimmune (Inst); Amcure (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Cristal Therapeutics (Inst); Eisai (Inst); Lilly (Inst); Novartis (Inst); Philogen (Inst); Pique (Inst); Swedish Orphan Biovitrum (Inst)
Speakers' Bureau - Bayer; Eisai; GlaxoSmithKline; Lilly; Novartis; Swedish Orphan Biovitrum
Research Funding - Bayer (Inst); Blueprint Medicines (Inst); CoBioRes NV (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - PharmaMar